Metabolic Derangements in Acute Heart Failure Syndrome

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00682175

Enrollment

100

Registered

2008-05-22

Start date

2008-05-31

Completion date

2009-03-31

Last updated

2009-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive Heart Failure

Keywords

Congestive Heart Failure

Brief summary

To determine the association of both neurohormonal and hemodynamic alterations associated with metabolic abnormalities in acute heart failure syndrome.

Interventions

OTHERObservational

Pulmonary Artery pressure (PA), pulmonary capillary wedge pressure (PCWP), cardiac output (CO), and cardiac index (CI). This data will be collected after 24 ± 2 and 48 ± 2 hours of standard heart failure therapy

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult (age \> 18 yrs) patients admitted to the Heart Failure Intensive Care Unit (H22) with Acute Heart Failure Syndrome (AHFS) requiring placement of a Pulmonary Artery catheter for hemodynamically guided therapy.

Exclusion criteria

* History of Congenital Heart Disease. * Acute HF in the setting of acute myocardial infarction. * Severe Anemia * Patients listed for cardiac transplantation. * Terminal Malignancy, AIDS or CNS disease. * Concomitant sepsis, ARDS, trauma, aortic dissection, or pericardial tamponade

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026